ANDA 78300, held by Mn Pharms. Pamidronate Disodium.
As of Nov 15, 2026, ANDA 78300 (Pamidronate Disodium), held by Mn Pharms, was first approved by FDA on Mar 10, 2009, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 10, 2009 | Original application | Approved | None posted |
| Pamidronate Disodium30MG/VIAL · injectable;injection | Pamidronate Disodium | Discontinued |
| Pamidronate Disodium90MG/VIAL · injectable;injection | Pamidronate Disodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
